Amiodarone Injection 50 mg/mL

๐Ÿ“Œ Medicine Name:

Amiodarone Injection 50 mg/mL
(Also known as Amiodarone Hydrochloride for Injection)


๐Ÿ“‹ Description / Prescription:

Amiodarone injection is a prescription-only, Class III antiarrhythmic drug used intravenously (IV) in emergency or acute settings to treat life-threatening ventricular arrhythmias.

  • Form: Injectable solution
  • Strength: 50 mg/mL
  • Available concentrations: Typically in 3 mL ampoules or 150 mg/3 mL vials
  • Route: Intravenous infusion (IV only, not for IM or SC use)
  • Prescription Required: โœ”๏ธ Yes

๐Ÿฉบ Indications / Uses:

  • Ventricular tachycardia (VT) โ€“ especially hemodynamically unstable or pulseless
  • Ventricular fibrillation (VF) โ€“ refractory to defibrillation and epinephrine
  • Prevention of recurrent arrhythmias during or after cardiac resuscitation
  • Temporary arrhythmia control before oral therapy initiation

๐Ÿ”ฌ Nature / Mechanism of Action:

Amiodarone primarily blocks potassium channels (Class III), which prolongs repolarization and the action potential duration.
It also:

  • Inhibits sodium channels (Class I)
  • Shows beta-blocking (Class II) and calcium channel blocking (Class IV) effects
  • Slows SA node and AV node conduction, prolongs QT interval

๐Ÿงช Highly lipophilic, extensive tissue distribution
โณ Half-life (IV): Shorter than oral, but effects may persist due to tissue binding


โœ… Advantages / Benefits:

  • โœ… Rapid action during cardiac emergencies
  • โœ… Effective for both atrial and ventricular arrhythmias
  • โœ… Can be used when oral route is not feasible
  • โœ… Low proarrhythmic risk compared to other antiarrhythmics
  • โœ… Can convert or stabilize rhythm before cardioversion

๐Ÿ’‰ Common Dosage & Administration:

๐Ÿ”น For Pulseless VT/VF (Advanced Cardiac Life Support – ACLS):

  • Initial dose: 300 mg IV push (undiluted)
  • May repeat: 150 mg IV push if arrhythmia persists

๐Ÿ”น For Stable Wide-Complex Tachycardia / Recurrent VT/VF:

  • Loading dose: 150 mg in 100 mL D5W over 10 minutes
  • Followed by:
    • 360 mg over next 6 hours (1 mg/min)
    • Then 540 mg over 18 hours (0.5 mg/min)
  • Max dose (per 24 h): Typically 2.2 g

๐Ÿงด Diluent: Use D5W (5% dextrose in water)
โ— Always use an in-line filter (0.22 micron) during IV infusion


๐Ÿ“ฆ Common Packaging:

  • Glass ampoules or vials:
    • 150 mg/3 mL (50 mg/mL)
    • May also come in pre-filled syringes
  • Supplied in boxes with 1, 5, or 10 ampoules/vials
  • Amber-colored to protect from light

๐ŸŒก๏ธ Storage Conditions:

  • Store at 15โ€“25ยฐC (59โ€“77ยฐF)
  • Protect from light (photosensitive)
  • Do not refrigerate โ€“ may cause crystallization
  • Inspect for precipitation or discoloration before use

โš ๏ธ Precautions / Warnings:

Contraindications:

  • Severe sinus node dysfunction or AV block (without pacemaker)
  • Bradycardia, cardiogenic shock
  • Known iodine sensitivity
  • Hypotension unresponsive to treatment

Caution in:

  • Liver, lung, or thyroid disease
  • Prolonged QT interval or electrolyte imbalance
  • Use with other QT-prolonging agents

๐Ÿงช Monitor:

  • ECG continuously during infusion
  • Blood pressure (risk of hypotension)
  • Liver enzymes, pulmonary function, thyroid function
  • Signs of bradycardia, torsades de pointes, or heart block

Adverse Effects (IV use):

  • Hypotension (most common, especially with bolus)
  • Bradycardia
  • Phlebitis (prefer central line if long-term infusion)
  • Arrhythmia worsening (rare)
  • Liver enzyme elevation

๐Ÿ‘ฉโ€โš•๏ธ Patient Advice (if conscious):

  • Explain possible effects: dizziness, flushing, slow heartbeat
  • Warn about light sensitivity and the need for sun protection post-discharge
  • After stabilization, oral amiodarone may be continued
  • Report symptoms like:
    • Persistent cough, breathing difficulty
    • Vision changes
    • Weight gain/loss, fatigue (thyroid signs)

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button